| List | Section | Observation |
|---|---|---|
| Training CSamouge 2022 | 2.2 Opioid analgesics |
Others observations: Therapeutic alternatives: hydrormorphone and oxycodone |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| Training CSamouge 2022 | 2.2 Opioid analgesics |
Others observations: Therapeutic alternatives: hydrormorphone and oxycodone |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| Training CSamouge 2022 | 2.2 Opioid analgesics |
Others observations: Therapeutic alternatives: hydrormorphone and oxycodone |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| Training CSamouge 2022 | 2.2 Opioid analgesics |
Others observations: Therapeutic alternatives: hydrormorphone and oxycodone |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| Training CSamouge 2022 | 2.2 Opioid analgesics |
Others observations: Therapeutic alternatives: hydrormorphone and oxycodone |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 1.3. Preoperative medication and sedation for short-term procedures | No observations |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics |
Others observations: Therapeutic alternatives: hydrormorphone, oxycodone |
| PAHO Strategic Fund Medicine List | 1.1. Opioid analgesics | No observations |
| Training CSamouge 2022 | 1.3 Preoperative medication and sedation for short-term procedures | No observations |
| List | Section | Observation |
|---|---|---|
| Training CSamouge 2022 | 2.2 Opioid analgesics |
Others observations: Therapeutic alternatives: hydrormorphone and oxycodone |
| List | Section | Observation |
|---|---|---|
| Bolivia | LINAME 2011 - 2013 | No observations |
| List | Section | Observation |
|---|---|---|
| Ecuador | Essential Medicines List - Ecuador | No observations |
| List | Section | Observation |
|---|---|---|
| Colombia | 2.1 Narcotic Analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| Cuba | 2.2 Analgésicos opioides |
Others observations: Liophylized for epidural and intrathecal injection |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics |
Others observations: Therapeutic alternatives: hydrormorphone, oxycodone |
| PAHO Strategic Fund Medicine List | 1.1. Opioid analgesics |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| Training CSamouge 2022 | 2.2 Opioid analgesics |
Others observations: Therapeutic alternatives: hydrormorphone and oxycodone |
| List | Section | Observation |
|---|---|---|
| Peru | 2.2 Analgesic Opiates | No observations |
| List | Section | Observation |
|---|---|---|
| Ecuador | Essential Medicines List - Ecuador | No observations |
| List | Section | Observation |
|---|---|---|
| Colombia | 13.1 Narcotic Analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| Chile | Essential and Prioritized Medications | No observations |
| List | Section | Observation |
|---|---|---|
| Chile | Essential and Prioritized Medications | No observations |
| List | Section | Observation |
|---|---|---|
| Ecuador | Essential Medicines List - Ecuador | No observations |
| List | Section | Observation |
|---|---|---|
| Peru | 2.2 Analgesic Opiates | No observations |
| List | Section | Observation |
|---|---|---|
| Peru | 2.2 Analgesic Opiates | No observations |
| List | Section | Observation |
|---|---|---|
| Training CSamouge 2022 | 2.2 Opioid analgesics |
Others observations: Therapeutic alternatives: hydrormorphone and oxycodone |
| List | Section | Observation |
|---|---|---|
| Bolivia | LINAME 2011 - 2013 | No observations |
| Training CSamouge 2022 | 2.2 Opioid analgesics |
Others observations: Therapeutic alternatives: hydrormorphone and oxycodone |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| PAHO Strategic Fund Medicine List | 1.1. Opioid analgesics | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| PAHO Strategic Fund Medicine List | 1.1. Opioid analgesics |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| Peru | 2.2 Analgesic Opiates | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| PAHO Strategic Fund Medicine List | 1.1. Opioid analgesics |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| Chile | Essential and Prioritized Medications | No observations |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| Chile | Essential and Prioritized Medications | No observations |
| Colombia | 13.1 Narcotic Analgesics | No observations |
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 2.2. Opioid analgesics | No observations |